ARCHIVES

Conversation with The Cancer Letter: Einhorn: “I Still Harbor Hope For Similar Success Stories”

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

Ultmann Appeals For Better Funding, Cancer Act Renewal

June 28, 1985

BSA Approves Six Concepts

July 19, 2013

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

Congress Orders Programs In Nutrition Research; Cancer Act Extension Beefs Up NCI Chief’s Authority

July 12, 1974